KYMR Kymera Therapeutics, Inc. - Common Stock
$123,55
Prezzo · Ago 19, 2026
Fondamentali al Ago 5, 2026
Intervallo 52 sett.
$40–$130
93% of range
Rating Analisti
BUY
30 analysts
Prezzo Obiettivo
$131
+6% upside
P/E (TTM)
-33.5
ROE
-24.4%
Margine di Profitto Netto
-794.0%
Informazioni su Kymera Therapeutics, Inc. - Common Stock Panoramica della società da Wikipedia
KYMR Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$123.55
Capitalizzazione di Mercato
$10.05B
P/E (TTM)
-33.5
EPS (TTM)
$-3.69
Ricavi (TTM)
$39M
Rendimento div.
—
ROE
-24.4%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$40 – $130
KYMR Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$39M
2019-12-31
→
2025-12-31
EPS
$-3.69
2020-12-31
→
2025-12-31
Flusso di cassa libero
$-234M
2020-12-31
→
2025-12-31
Margini
-794.0%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
KYMR
Mediana dei peer
P/E (TTM)
-33.5
16.0
P/S (TTM)
256.2
32.5
P/B
6.4
3.9
Price / FCF (Prezzo / FCF)
-42.9
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
KYMR
Mediana dei peer
Operating Margin (Margine Operativo)
-891.1%
—
Net Profit Margin (Margine di Profitto Netto)
-794.0%
-93.3%
ROA
-22.9%
-22.2%
ROE
-24.4%
-37.6%
ROIC
-22.1%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
KYMR
Mediana dei peer
Current Ratio (Rapporto corrente)
10.5
5.7
Quick Ratio
4.3
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
KYMR
Mediana dei peer
Revenue YoY (Ricavi YoY)
-16.7%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
-5.7%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
2.9%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
KYMR
Mediana dei peer
KYMR Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
30 analisti
- Acquisto forte 10 33,3%
- Compra 16 53,3%
- Mantieni 4 13,3%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
22 analisti · 2026-08-16
Mediana
$133.00
Ora
$123.55
Basso
$111.00
Alto
$155.00
Target mediano
$133.00
+7,6%
Target medio
$130.91
+6,0%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.00%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-0.62 | $-0.73 | 0.11% |
| 31 Marzo 2026 | $-0.71 | $-0.90 | 0.19% |
| 31 Dicembre 2025 | $-0.97 | $-0.81 | -0.16% |
| 30 Settembre 2025 | $-0.94 | $-0.82 | -0.12% |
| 30 Giugno 2025 | $-0.95 | $-0.83 | -0.12% |
| 31 Marzo 2025 | $-0.82 | $-0.93 | 0.11% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| PRAX | $7.43B | -21.9 | 249.5% | — | -47.3% | — |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
| SMMT | $13.56B | -12.1 | — | — | -235.1% | — |
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
| SYRE | $2.56B | 10.1 | -62.0% | — | -26.5% | — |
| PCVX | $6.05B | -8.2 | — | — | -26.6% | — |
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $39M | $47M | $79M | $47M | $73M | $34M | $3M | |
| Cost of Revenue | $39M | $47M | $79M | $47M | · | · | · | |
| R&D Expense | $317M | $240M | $189M | $164M | $137M | $62M | $37M | |
| SG&A Expense | $68M | $64M | $55M | $44M | $36M | $18M | $8M | |
| Operating Expenses | $389M | $309M | $244M | $208M | $173M | $80M | $45M | |
| Operating Income | $-349M | $-262M | $-166M | $-161M | $-101M | $-46M | $-42M | |
| Other Non-op | $38M | $38M | $19M | $6M | $313.0K | $711.0K | $959.0K | |
| Pretax Income | $-311M | · | · | · | · | · | · | |
| Income Tax | $0 | · | · | $0 | $0 | $0 | $0 | |
| Net Income | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | $-41M | |
| EPS (Basic) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| EPS (Diluted) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| Shares (Basic) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| Shares (Diluted) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| EBITDA | $-341M | $-254M | $-162M | $-158M | $-98M | $-45M | · |
Stato Patrimoniale 21
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $357M | $120M | $110M | $68M | $48M | $31M | $76M | |
| Receivables | $0 | $0 | $15M | $0 | · | · | · | |
| Prepaid Expense | $23M | $22M | $12M | $10M | $9M | $5M | $888.0K | |
| Current Assets | $871M | $510M | $405M | $419M | $451M | $302M | $93M | |
| PP&E (Net) | $43M | $50M | $48M | $13M | $12M | $11M | $4M | |
| PP&E (Gross) | $65M | $67M | $59M | $20M | $16M | $13M | $5M | |
| Accum. Depreciation | $22M | $16M | $10M | $7M | $4M | $2M | $1M | |
| Other Non-current Assets | $9M | $2M | $2M | $3M | $2M | $30.0K | $2M | |
| Total Assets | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Accounts Payable | $4M | $6M | $7M | $4M | $4M | $4M | $3M | |
| Accrued Liabilities | $42M | $35M | $34M | $28M | $23M | $10M | $5M | |
| Current Liabilities | $83M | $68M | $86M | $71M | $93M | $111M | $35M | |
| Capital Leases | $67M | $72M | $77M | $12M | $13M | $14M | $17M | |
| Other Non-current Liabilities | · | $0 | $0 | $248.0K | $66.0K | $100.0K | · | |
| Total Liabilities | $163M | $142M | $181M | $113M | $146M | $203M | $82M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | · | |
| Retained Earnings | $-1.07B | $-755M | $-531M | $-384M | $-229M | $-129M | $-76M | |
| AOCI | $2M | $-1M | $-552.0K | $-5M | $-660.0K | $-128.0K | $6.0K | |
| Stockholders' Equity | $1.58B | $836M | $395M | $490M | $460M | $284M | $-74M | |
| Liabilities + Equity | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Shares Outstanding | 81,323,532 | 64,890,193 | 55,585,305 | 55,039,380 | 51,536,181 | 44,482,186 | 1,929,516 |
Flusso di cassa 9
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $7M | $4M | $3M | $2M | $2M | $825.0K | |
| Stock-based Comp | $60M | $55M | $43M | $35M | $25M | $5M | $1M | |
| Other Non-cash | $10M | $-33M | $-3M | $-37M | $-56M | $127M | · | |
| Operating Cash Flow | $-233M | $-195M | $-103M | $-153M | $-129M | $88M | $18M | |
| CapEx | $1M | $13M | $34M | $3M | $2M | $9M | $532.0K | |
| Investing Cash Flow | $-521M | $-404M | $140M | $21M | $-100M | $-423M | $-16M | |
| Financing Cash Flow | $991M | $609M | $4M | $153M | $250M | $289M | $35M | |
| Net Change in Cash | $237M | $10M | $41M | $20M | $21M | $-45M | $36M | |
| Free Cash Flow | $-234M | $-207M | $-137M | $-156M | $-131M | $79M | · |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% | -136.1% | · | |
| Net Margin | -794.0% | -475.6% | -187.0% | -330.6% | -137.6% | -134.0% | · | |
| Pretax Margin | -794.0% | · | · | · | · | · | · | |
| EBITDA Margin | -869.9% | -540.2% | -206.1% | -338.0% | -134.7% | -130.9% | · | |
| ROA | -22.9% | -28.8% | -24.9% | -25.6% | -18.3% | -15.1% | · | |
| ROE | -24.4% | -25.9% | -37.2% | -30.9% | -21.3% | -15.8% | · | |
| ROIC | -22.1% | · | · | · | · | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 | 2.7 | · | |
| Quick Ratio | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 | 0.3 | · |
Efficienza 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | 6.3 | 10.5 | · | · | · | · |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -16.7% | -40.1% | 67.8% | -35.7% | 114.0% | · | · | |
| Revenue CAGR 3Y | -5.7% | -13.5% | 32.2% | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $39M | $47M | $79M | $47M | $73M | $34M | · | |
| Net Income TTM | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | · | |
| Market Cap | $6.33B | $2.61B | · | $1.37B | $3.27B | $2.76B | · | |
| P/E | -21.1 | -13.5 | -10.1 | -8.7 | -30.4 | -19.7 | · | |
| P/S | 161.4 | 55.5 | · | 29.3 | 44.9 | 81.0 | · | |
| P/B | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Tangible Book | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Cash Flow | -27.2 | -13.4 | · | -9.0 | -25.4 | 31.3 | · | |
| P / FCF | -27.0 | -12.6 | · | -8.8 | -25.1 | 34.9 | · | |
| Earnings Yield | -4.7% | -7.4% | -9.9% | -11.5% | -3.3% | -5.1% | · |
Conto Economico 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | $48M | $5M | $17M | $9M | $16M | $10M | |
| Cost of Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | · | · | · | · | · | · | |
| R&D Expense | $119M | $98M | $84M | $74M | $78M | $80M | $72M | $60M | $59M | $49M | $53M | $48M | $46M | $42M | $43M | $44M | |
| SG&A Expense | $21M | $20M | $17M | $17M | $18M | $16M | $16M | $15M | $17M | $14M | $14M | $14M | $14M | $13M | $12M | $11M | |
| Operating Expenses | $141M | $119M | $101M | $95M | $96M | $97M | $88M | $76M | $77M | $68M | $67M | $62M | $60M | $55M | $55M | $54M | |
| Operating Income | $-76M | $-84M | $-98M | $-93M | $-85M | $-74M | $-81M | $-72M | $-51M | $-58M | $-19M | $-58M | $-43M | $-45M | $-39M | $-45M | |
| Other Non-op | $14M | $15M | $11M | $10M | $8M | $9M | $10M | $10M | $9M | $9M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $100.0K | $0 | · | $0 | |
| Net Income | $-61M | $-69M | $-87M | $-82M | $-77M | $-66M | $-71M | $-62M | $-42M | $-49M | $-14M | $-53M | $-39M | $-41M | $-35M | $-43M | |
| EPS (Basic) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| EPS (Diluted) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| Shares (Basic) | 98,177,158 | 97,534,269 | -163,405,637 | 87,300,286 | 80,449,405 | 80,146,531 | -144,911,702 | 76,125,975 | 73,059,398 | 70,770,320 | -116,570,361 | 58,421,859 | 58,326,963 | 58,187,038 | -104,025,850 | 54,535,514 | |
| Shares (Diluted) | 98,177,158 | 97,534,269 | -163,405,637 | 87,300,286 | 80,449,405 | 80,146,531 | -144,911,702 | 76,125,975 | 73,059,398 | 70,770,320 | -116,570,361 | 58,421,859 | 58,326,963 | 58,187,038 | -104,025,850 | 54,535,514 | |
| EBITDA | $-76M | $-82M | · | $-93M | $-85M | $-72M | · | $-72M | $-51M | $-56M | · | $-58M | $-43M | $-44M | · | $-45M |
Stato Patrimoniale 21
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $124M | $144M | $357M | $113M | $336M | $90M | $120M | $111M | $68M | $94M | $110M | $81M | $52M | $50M | $68M | $156M | |
| Receivables | $20M | · | · | · | $40M | · | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $26M | $27M | $23M | $23M | $23M | $18M | $22M | $17M | $14M | $15M | · | $14M | $14M | $11M | · | $9M | |
| Current Assets | $737M | $677M | $871M | $528M | $728M | $501M | $510M | $569M | $525M | $537M | · | $376M | $385M | $412M | · | $494M | |
| PP&E (Net) | $40M | $42M | $43M | $45M | $49M | $49M | $50M | $51M | $52M | $49M | · | $36M | $27M | $17M | · | $13M | |
| PP&E (Gross) | $66M | $66M | $65M | $67M | $69M | $67M | $67M | $65M | $64M | $60M | · | $46M | $36M | $25M | · | $19M | |
| Accum. Depreciation | $26M | $24M | $22M | $22M | $20M | $18M | $16M | $14M | $12M | $11M | · | $10M | $9M | $8M | · | $6M | |
| Other Non-current Assets | $7M | $8M | $9M | $7M | $5M | $3M | $2M | $0 | $2M | $2M | · | $3M | $3M | $3M | · | $3M | |
| Total Assets | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Accounts Payable | $9M | $13M | $4M | $6M | $6M | $10M | $6M | $6M | $7M | $7M | · | $5M | $4M | $6M | · | $6M | |
| Accrued Liabilities | $48M | $35M | $42M | $29M | $28M | $23M | $35M | $27M | $24M | $16M | · | $26M | $22M | $19M | · | $25M | |
| Current Liabilities | $71M | $63M | $83M | $72M | $88M | $59M | $68M | $67M | $62M | $56M | · | $63M | $55M | $62M | · | $91M | |
| Capital Leases | $64M | $66M | $67M | $68M | $70M | $71M | $72M | $74M | $75M | $76M | · | $77M | $71M | $64M | · | $12M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $8.0K | $230.0K | $237.0K | · | $256.0K | |
| Total Liabilities | $136M | $129M | $163M | $156M | $160M | $132M | $142M | $142M | $141M | $157M | · | $157M | $147M | $152M | · | $126M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $-1.20B | $-1.14B | $-1.07B | $-979M | $-897M | $-820M | $-755M | $-684M | $-621M | $-579M | · | $-516M | $-464M | $-425M | · | $-349M | |
| AOCI | $-7M | $-4M | $2M | $2M | $279.0K | $-58.0K | $-1M | $2M | $-2M | $-2M | · | $-2M | $-4M | $-3M | · | $-6M | |
| Stockholders' Equity | $1.51B | $1.54B | $1.58B | $946M | $971M | $786M | $836M | $893M | $685M | $711M | $395M | $396M | $435M | $462M | $490M | $513M | |
| Liabilities + Equity | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Shares Outstanding | 82,788,253 | 82,182,101 | 81,323,532 | 71,741,174 | 70,557,442 | 65,112,714 | 64,890,193 | 64,748,226 | 61,572,383 | 61,353,146 | · | 55,450,239 | 55,390,259 | 55,276,226 | · | 54,751,429 |
Flusso di cassa 9
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $891.0K | $895.0K | $900.0K | $879.0K | $818.0K | $767.0K | |
| Stock-based Comp | $19M | $16M | $14M | $16M | $15M | $14M | $14M | $15M | $14M | $12M | $11M | $12M | $11M | $9M | $9M | $9M | |
| Other Non-cash | · | $-38M | · | · | · | $-30M | · | · | · | $-4M | · | · | · | $-13M | · | · | |
| Operating Cash Flow | $-54M | $-89M | $-67M | $-27M | $-60M | $-79M | $-62M | $-50M | $-43M | $-40M | $8M | $-32M | $-35M | $-44M | $-40M | $-34M | |
| CapEx | $473.0K | $434.0K | $106.0K | $181.0K | $695.0K | $467.0K | $936.0K | $-189.0K | $5M | $7M | $12M | $8M | $11M | $4M | $373.0K | $1M | |
| Investing Cash Flow | $20M | $-143M | $-394M | $-235M | $60M | $49M | $69M | $-158M | $16M | $-331M | $19M | $61M | $36M | $25M | $-50M | $-37M | |
| Financing Cash Flow | $14M | $19M | $705M | $40M | $246M | $258.0K | $3M | $251M | $1M | $354M | $2M | $-206.0K | $1M | $1M | $2M | $150M | |
| Net Change in Cash | $-20M | $-213M | $244M | $-223M | $246M | $-30M | $10M | $43M | $-26M | $-16M | $29M | $29M | $2M | $-18M | $-87M | $79M | |
| Free Cash Flow | · | $-89M | · | · | · | $-80M | · | · | · | $-47M | · | · | · | $-48M | · | · |
Redditività 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -116.3% | -244.9% | · | -3347.4% | -736.8% | -336.8% | · | -1927.9% | -198.5% | -562.2% | · | -1216.4% | -262.7% | -478.8% | · | -469.9% | |
| Net Margin | -94.2% | -201.5% | · | -2973.0% | -667.6% | -296.8% | · | -1670.3% | -164.0% | -472.0% | · | -1118.2% | -235.0% | -432.4% | · | -450.2% | |
| EBITDA Margin | -116.3% | -239.0% | · | -3347.4% | -736.8% | -327.5% | · | -1927.9% | -198.5% | -548.0% | · | -1216.4% | -262.7% | -469.5% | · | -469.9% | |
| ROA | -4.4% | -5.3% | · | -7.7% | -7.8% | -7.3% | · | -7.9% | -6.0% | -6.6% | · | -8.9% | -7.0% | -7.0% | · | -6.7% | |
| ROE | -4.9% | -5.9% | · | -8.9% | -9.2% | -8.8% | · | -9.7% | -7.5% | -8.3% | · | -11.6% | -9.3% | -9.2% | · | -8.6% |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 10.8 | · | 7.4 | 8.3 | 8.5 | · | 8.5 | 8.5 | 9.6 | · | 5.9 | 7.1 | 6.6 | · | 5.4 | |
| Quick Ratio | 2.0 | 2.3 | · | 1.6 | 4.3 | 1.5 | · | 1.7 | 1.1 | 1.7 | · | 1.3 | 1.0 | 0.8 | · | 1.7 |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 2.2 | · | · | · | 0.6 | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $114M | $71M | · | $40M | $63M | $62M | · | $44M | $57M | $41M | · | $40M | $47M | $40M | · | $51M | |
| Net Income TTM | $-289M | $-294M | · | $-287M | $-247M | $-219M | · | $-206M | $-182M | $-181M | · | $-176M | $-163M | $-161M | · | $-149M | |
| Market Cap | $9.49B | $6.84B | · | $4.06B | $3.08B | $1.78B | · | $3.06B | $1.84B | $2.47B | · | $771M | $1.27B | $1.64B | · | $1.19B | |
| P/E | -35.6 | -24.4 | · | -16.0 | -13.8 | -9.4 | · | -15.8 | -10.5 | -13.6 | · | -4.5 | -7.8 | -9.9 | · | -7.7 | |
| P/S | 83.6 | 96.8 | · | 101.3 | 48.9 | 28.8 | · | 69.0 | 32.1 | 60.2 | · | 19.1 | 27.1 | 40.8 | · | 23.4 | |
| P/B | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Tangible Book | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Cash Flow | · | -77.0 | · | · | · | -22.5 | · | · | · | -62.3 | · | · | · | -37.3 | · | · | |
| P / FCF | · | -76.7 | · | · | · | -22.4 | · | · | · | -52.5 | · | · | · | -34.1 | · | · | |
| Earnings Yield | -2.8% | -4.1% | · | -6.2% | -7.3% | -10.6% | · | -6.3% | -9.5% | -7.4% | · | -22.0% | -12.8% | -10.1% | · | -13.1% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $39M | $47M | $79M | $47M | $73M |
| Margine Operativo % | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% |
| Utile netto | $-311M | $-224M | $-147M | $-155M | $-100M |
| EPS Diluito | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 |
| Quick Ratio | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-234M | $-207M | $-137M | $-156M | $-131M |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 305 filer · $8.0B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 58 (+19 vs trimestre precedente) | 22 (-14 vs trimestre precedente) | 94 (+1 vs trimestre precedente) | 78 (+5 vs trimestre precedente) | +11.8M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $992.725.940 | 8.657.242 | 12,48% | Azioni |
| FMR LLC | $985.896.654 | 8.597.686 | 12,40% | Azioni |
| Avoro Capital Advisors LLC | $857.129.238 | 7.474.747 | 10,78% | Azioni |
| BVF INC/IL | $444.008.203 | 3.872.052 | 5,58% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $376.085.378 | 3.279.719 | 4,73% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $343.114.771 | 2.992.193 | 4,31% | Azioni |
| Siren, L.L.C. | $336.651.626 | 2.935.830 | 4,23% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $336.255.785 | 2.932.378 | 4,23% | Azioni |
| Atlas Venture Life Science Advisors, LLC | $326.527.526 | 2.847.541 | 4,11% | Azioni |
| STATE STREET CORP | $313.877.705 | 2.737.226 | 3,95% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $181.558.708 | 1.582.987 | 2,28% | Azioni |
| Capital Research Global Investors | $159.262.984 | 1.388.881 | 2,00% | Azioni |
| Driehaus Capital Management LLC | $105.408.448 | 919.233 | 1,33% | Azioni |
| GOLDMAN SACHS GROUP INC | $101.597.391 | 885.998 | 1,28% | Azioni |
| Merck & Co., Inc. | $88.544.161 | 772.165 | 1,11% | Azioni |
| NORGES BANK | $86.833.399 | 757.246 | 1,09% | Azioni |
| FEDERATED HERMES, INC. | $85.933.469 | 749.398 | 1,08% | Azioni |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $84.955.104 | 740.866 | 1,07% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $81.750.884 | 981.521 | 1,03% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $77.152.155 | 672.819 | 0,97% | Azioni |
| Holocene Advisors, LP | $72.996.514 | 636.579 | 0,92% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60.744.024 | 529.729 | 0,76% | Azioni |
| EVENTIDE ASSET MANAGEMENT, LLC | $57.811.287 | 504.210 | 0,73% | Azioni |
| JENNISON ASSOCIATES LLC | $57.676.487 | 502.978 | 0,73% | Azioni |
| Woodline Partners LP | $57.434.534 | 500.868 | 0,72% | Azioni |
| Rock Springs Capital Management LP | $51.963.399 | 453.156 | 0,65% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $51.570.654 | 449.731 | 0,65% | Azioni |
| Boxer Capital Management, LLC | $49.204.897 | 429.100 | 0,62% | Azioni |
| Pictet Asset Management Holding SA | $44.984.008 | 395.540 | 0,57% | Azioni |
| BRAIDWELL LP | $43.363.951 | 378.163 | 0,55% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $43.100.784 | 375.868 | 0,54% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $42.585.457 | 371.374 | 0,54% | Azioni |
| Clearbridge Investments, LLC | $39.815.871 | 347.221 | 0,50% | Azioni |
| Octagon Capital Advisors LP | $35.547.700 | 310.000 | 0,45% | Azioni |
| Nextech Invest Ltd. | $31.981.004 | 278.896 | 0,40% | Azioni |
| Alyeska Investment Group, L.P. | $31.701.095 | 276.455 | 0,40% | Azioni |
| TD Asset Management Inc | $31.293.443 | 272.900 | 0,39% | Azioni |
| TWO SIGMA ADVISERS, LP | $29.085.378 | 373.800 | 0,37% | Azioni |
| Commodore Capital LP | $28.667.500 | 250.000 | 0,36% | Azioni |
| RTW INVESTMENTS, LP | $27.520.800 | 240.000 | 0,35% | Azioni |
| GILDER GAGNON HOWE & CO LLC | $26.265.508 | 229.053 | 0,33% | Azioni |
| Polar Capital Holdings Plc | $23.363.668 | 203.747 | 0,29% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $22.934.000 | 200.000 | 0,29% | Azioni |
| Candriam S.C.A. | $22.096.270 | 192.880 | 0,28% | Azioni |
| BANK OF AMERICA CORP /DE/ | $21.627.335 | 188.605 | 0,27% | Azioni |
| Eagle Health Investments LP | $19.052.191 | 166.148 | 0,24% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $17.189.950 | 149.908 | 0,22% | Azioni |
| DIADEMA PARTNERS LP | $17.166.099 | 149.700 | 0,22% | Opzione Call |
| Foresite Capital Management VI LLC | $16.779.890 | 146.332 | 0,21% | Azioni |
| WCM INVESTMENT MANAGEMENT, LLC | $16.595.869 | 151.810 | 0,21% | Azioni |
| JANE STREET GROUP, LLC | $15.732.724 | 137.200 | 0,20% | Opzione Call |
| Deer Management Co. LLC | $14.436.380 | 125.895 | 0,18% | Azioni |
| TimesSquare Capital Management, LLC | $14.063.183 | 168.846 | 0,18% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $13.794.801 | 120.300 | 0,17% | Opzione Call |
| Caption Management, LLC | $13.760.400 | 120.000 | 0,17% | Opzione Put |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $13.703.409 | 119.503 | 0,17% | Azioni |
| BOONE CAPITAL MANAGEMENT LLC | $12.977.548 | 113.173 | 0,16% | Azioni |
| ARMISTICE CAPITAL, LLC | $12.186.210 | 106.272 | 0,15% | Azioni |
| First Turn Management, LLC | $11.757.459 | 102.533 | 0,15% | Azioni |
| Ensign Peak Advisors, Inc | $11.198.672 | 97.660 | 0,14% | Azioni |
| Squarepoint Ops LLC | $11.144.663 | 97.189 | 0,14% | Azioni |
| Swiss National Bank | $10.331.767 | 90.100 | 0,13% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $10.262.276 | 89.494 | 0,13% | Azioni |
| Bank of New York Mellon Corp | $9.823.664 | 85.669 | 0,12% | Azioni |
| RHUMBLINE ADVISERS | $9.252.017 | 80.684 | 0,12% | Azioni |
| JPMORGAN CHASE & CO | $9.149.756 | 81.205 | 0,12% | Azioni |
| Burkehill Global Management, LP | $8.600.250 | 75.000 | 0,11% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $8.524.567 | 74.340 | 0,11% | Azioni |
| CITIGROUP INC | $8.504.959 | 74.169 | 0,11% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8.462.646 | 73.800 | 0,11% | Opzione Put |
| CITADEL ADVISORS LLC | $8.328.253 | 72.628 | 0,10% | Azioni |
| FIFTH THIRD BANCORP | $7.529.104 | 65.659 | 0,09% | Azioni |
| BlackRock, Inc. | $7.486.231 | 65.285 | 0,09% | Azioni |
| Yiheng Capital Management, L.P. | $7.274.665 | 63.440 | 0,09% | Azioni |
| XTX Topco Ltd | $7.052.320 | 61.501 | 0,09% | Azioni |
| FIRST TRUST ADVISORS LP | $7.037.068 | 61.368 | 0,09% | Azioni |
| Atika Capital Management LLC | $6.957.488 | 60.674 | 0,09% | Azioni |
| Nicholas Investment Partners, LP | $6.257.427 | 54.569 | 0,08% | Azioni |
| Ikarian Capital, LLC | $5.779.368 | 50.400 | 0,07% | Opzione Put |
| Patient Square Capital LP | $5.446.825 | 47.500 | 0,07% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $5.250.281 | 45.786 | 0,07% | Azioni |
| PEREGRINE CAPITAL MANAGEMENT LLC | $5.237.094 | 45.671 | 0,07% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4.687.728 | 56.282 | 0,06% | Azioni |
| UBS Group AG | $4.678.880 | 40.803 | 0,06% | Azioni |
| AXA Investment Managers S.A. | $4.558.224 | 80.534 | 0,06% | Azioni |
| VOYA INVESTMENT MANAGEMENT LLC | $4.451.260 | 38.818 | 0,06% | Azioni |
| MARSHALL WACE, LLP | $4.273.177 | 37.265 | 0,05% | Azioni |
| STATE OF WISCONSIN INVESTMENT BOARD | $4.223.640 | 36.833 | 0,05% | Azioni |
| MetLife Investment Management, LLC | $4.184.767 | 36.494 | 0,05% | Azioni |
| Rafferty Asset Management, LLC | $4.046.360 | 35.287 | 0,05% | Azioni |
| Odyssean, LLC | $3.954.395 | 34.485 | 0,05% | Azioni |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $3.851.880 | 33.591 | 0,05% | Azioni |
| CITADEL ADVISORS LLC | $3.841.445 | 33.500 | 0,05% | Opzione Put |
| Aquilo Capital Management, LLC | $3.791.320 | 138.521 | 0,05% | Azioni |
| Nan Fung Group Holdings Ltd | $3.540.436 | 30.875 | 0,04% | Azioni |
| Moody Aldrich Partners LLC | $3.440.788 | 30.006 | 0,04% | Azioni |
| SEVEN GRAND MANAGERS, LLC | $3.440.100 | 30.000 | 0,04% | Azioni |
| 683 Capital Management, LLC | $3.440.100 | 30.000 | 0,04% | Opzione Put |
| CITADEL ADVISORS LLC | $3.428.633 | 29.900 | 0,04% | Opzione Call |
| NEW YORK STATE COMMON RETIREMENT FUND | $3.300.203 | 28.780 | 0,04% | Azioni |
Insider aziendali 24 insider · 10 dirigenti · 13 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Nello Mainolfi | Chief Executive Officer | 07 Luglio 2026 M | 666.568 | 0 | 21 | $-34.875.625 |
| Bruce N. Jacobs | Chief Financial Officer | 30 Giugno 2026 M | 244.883 | 0 | 16 | $-13.917.105 |
| Jeremy G Chadwick | Chief Operating Officer | 27 Maggio 2026 S | 44.018 | 0 | 29 | $-15.599.618 |
| Terence Rooney | Chief Medical Officer | 27 Luglio 2026 A | 38.000 | 0 | 0 | $0 |
| Noah Goodman | Chief Business Officer | 01 Luglio 2026 S | 47.179 | 0 | 9 | $-2.223.845 |
| Jared Gollob | Chief Medical Officer | 02 Marzo 2026 A | 117.134 | 0 | 18 | $-9.134.491 |
| Brian Adams | Chief Legal Officer | 02 Marzo 2026 A | 56.625 | 0 | 0 | $0 |
| Ellen Chiniara | Chief Legal Officer | 03 Marzo 2025 A | 80.085 | 0 | 0 | $0 |
| Elaine Caughey | Chief Business Officer | 01 Marzo 2023 A | 18.986 | 0 | 0 | $0 |
| Richard Chesworth | Chief Scientific Officer | 27 Agosto 2021 M | 0 | 0 | 0 | $0 |
| Bruce Booth | Direttore | 29 Giugno 2026 S | 462.856 | 0 | 137 | $-195.559.433 |
| Hrustanovic Gorjan | Direttore | 24 Giugno 2026 A | — | 0 | 0 | $0 |
| Elena Ridloff | Direttore | 24 Giugno 2026 A | 0 | 0 | 4 | $-1.285.644 |
| Pamela Esposito | Direttore | 24 Giugno 2026 A | 1.000 | 0 | 12 | $-3.054.174 |
| Jeffrey W. Albers | Direttore | 24 Giugno 2026 A | 0 | 0 | 3 | $-744.757 |
| Victor Sandor | Direttore | 24 Giugno 2026 A | — | 0 | 0 | $0 |
| John Maraganore | Direttore | 24 Giugno 2026 A | — | 0 | 0 | $0 |
| Leigh Morgan | Direttore | 18 Giugno 2024 A | — | 0 | 0 | $0 |
| Joanna Horobin | Direttore | 07 Giugno 2024 M | 0 | 0 | 0 | $0 |
| Donald William Nicholson | Direttore | 15 Giugno 2022 A | — | 0 | 0 | $0 |
| Steven Edward Hall | Direttore | 25 Agosto 2020 C | 2.192.249 | 0 | 0 | $0 |
| Andrew Hedin | Direttore | 20 Agosto 2020 A | — | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | Proprietario del 10% | 18 Maggio 2021 J | 5.763.012 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Proprietario del 10% | 25 Agosto 2020 C | 959.211 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N, Hrustanovic Gorjan ×2 depositi | 26 Giugno 2026 | 6,30% | Modifica | — | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×4 depositi | 11 Dicembre 2025 | 10,90% | Modifica | Struttura del capitale | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, GORJAN HRUSTANOVIC ×5 depositi | 09 Gennaio 2024 | — | Deposito iniziale | — | SEC |
| Vertex Pharmaceuticals Incorporated ×2 depositi | 05 Giugno 2023 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 64 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 4,23% | 84.154 NS | 31 Maggio 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,99% | 10.000 NS | 31 Maggio 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1,76% | 34.157 NS | 30 Aprile 2026 | N-PORT |
| GURU · Global X Funds | 1,04% | 7.506 NS | 30 Aprile 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,93% | 59.553 NS | 30 Aprile 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,67% | 3.077 NS | 30 Aprile 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,60% | 4.477 SH | 08 Agosto 2026 | Giornaliero |
| IBB · iShares Trust | 0,58% | 522.187 SH | 08 Agosto 2026 | Giornaliero |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,50% | 3.204 NS | 31 Maggio 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,39% | 24.697 NS | 30 Aprile 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,35% | 55.351 SH | 08 Agosto 2026 | Giornaliero |
| IWO · iShares Trust | 0,34% | 469.031 SH | 08 Agosto 2026 | Giornaliero |
| BIB · ProShares Trust | 0,33% | 3.017 NS | 31 Maggio 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,33% | 1.305 NS | 31 Maggio 2026 | N-PORT |
| ESSC · Strategy Shares | 0,31% | 979 NS | 30 Aprile 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 20.749 NS | 30 Aprile 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,22% | 360.394 SH | 08 Agosto 2026 | Giornaliero |
| VBK · VANGUARD INDEX FUNDS | 0,21% | 871.540 SH | 08 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,21% | 1.586.740 SH | 08 Agosto 2026 | Giornaliero |
| BKSE · BNY Mellon ETF Trust | 0,19% | 1.938 NS | 30 Aprile 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,19% | 32.324 SH | 08 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,14% | 24.820 NS | 30 Aprile 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,13% | 21.796 NS | 30 Aprile 2026 | N-PORT |
| ITWO · ProShares Trust | 0,12% | 2.699 NS | 31 Maggio 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,11% | 6.792 NS | 30 Aprile 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,11% | 294.706 NS | 31 Maggio 2026 | N-PORT |
| ISCV · iShares Trust | 0,09% | 5.956 SH | 08 Agosto 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,09% | 1.509.269 SH | 08 Agosto 2026 | Giornaliero |
| ISCG · iShares Trust | 0,09% | 8.334 SH | 08 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | 0,09% | 2.398 SH | 08 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 22.424 SH | 08 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,08% | 143.695 NS | 30 Aprile 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,08% | 726.357 SH | 08 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,08% | 9.461 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,08% | 134.854 SH | 08 Agosto 2026 | Giornaliero |
| ESML · iShares Trust | 0,08% | 21.257 SH | 08 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | 0,07% | 101.814 SH | 08 Agosto 2026 | Giornaliero |
| UWM · ProShares Trust | 0,07% | 2.111 NS | 31 Maggio 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,06% | 21.910 NS | 30 Aprile 2026 | N-PORT |
| URTY · ProShares Trust | 0,05% | 2.136 NS | 31 Maggio 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,05% | 61 NS | 31 Maggio 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 2.882 SH | 08 Agosto 2026 | Giornaliero |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 5.327 NS | 31 Maggio 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,03% | 1.604 NS | 31 Maggio 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,02% | 2.239 NS | 31 Maggio 2026 | N-PORT |
| HDG · ProShares Trust | 0,02% | 54 NS | 31 Maggio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 93.115 NS | 30 Aprile 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 19.514 NS | 31 Maggio 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 675 NS | 30 Aprile 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 2.916 NS | 30 Aprile 2026 | N-PORT |